Controversial Tanning Bed Regulations Rolled Back Amidst Lobbying Efforts
The FDA has backed off plans to impose stricter regulations on indoor tanning, drawing criticism from medical experts concerned about skin cancer risks.
In a move that has sparked controversy among health advocates, the Food and Drug Administration (FDA) has backtracked on its efforts to impose more stringent regulations on indoor tanning beds. This decision comes despite warnings from medical organizations about the serious health risks associated with the use of these devices, particularly in terms of increased skin cancer rates.
The Trump administration's health officials have opted to take a step back from the proposed tighter controls, a move that has been attributed, in part, to the lobbying efforts of high-profile figures such as Robert F. Kennedy Jr., a prominent opponent of stricter tanning bed regulations.
Source: NPR
